Cytoplasmic phospholipase A2 metabolites play a critical role in pulmonary tumor metastasis in mice

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3421-3427

  Jeong, Woo Chan ^a,b   Kim, Kyoung Jin ^c   Ju, Hye Won ^c   Back, Hae Kyung ^c   Kim, Hae Kyung ^b   Im, Suhn Young ^c   Lee, Hern Ku ^b  

^a Seoul Medical Center   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

5 lipoxygenase; Angiogenesis; Cyclooxygenase 2; Cytoplasmic phospholipase A2; Metalloproteinase; Tumor metastasis

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONYL TRIFLUOROMETHYL KETONE; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; DOCEBENONE; GELATINASE A; GELATINASE B; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; FEMALE; LUNG TUMOR; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CANCER INVASION; DRUG ANTAGONISM; ENZYMOLOGY; EXPERIMENTAL MELANOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CYCLOOXYGENASE 2; ENZYME INHIBITORS; FEMALE; LUNG NEOPLASMS; MATRIX METALLOPROTEINASES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOLIPASES A2, CYTOSOLIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77958530752     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Dannenberg AJ Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB and Subbaramaiah K: Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2: 544-551, 2001.
2. Nie D, Che M, Grignon D, Tang K and Honn KV: Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev 20: 195-206, 2001. (Pubitemid 34595268)
3. Nie D, Hillman GG, Geddes T, Tang K, Pierson C, Grignon DJ and Honn KV: Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res 58: 4047-4051, 1998.
4. Pidgeon GP, Kandouz M, Meram A and Honn KV: Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62: 2721-2727, 2002.
5. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM: Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809, 1996.
6. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O and Langenbach R: Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60: 4705-4708, 2000.
7. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclo-oxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
8. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S and Talbot IC: Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187: 295-301, 1999.
9. 2 in human colon cancer cells. Cancer Res 58: 362-366, 1998.
10. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081, 2001. (Pubitemid 33652360)
11. Samuelsson B, Dahlén SE, Lindgren JÅ, Rouzer CA and Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176, 1987.
12. Boado RJ, Pardridge WM, Vinters HV and Black KL: Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family. Proc Natl Acad Sci USA 89: 9044-9048, 1992.
13. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M and Mulshine JL: 5-Lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15: 2007-2009, 2001.
14. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A and Mulshine JL: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813, 1996.
15. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 96: 4803-4807, 1999.
16. 2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 8: 710-716, 2003.
17. 2). FEBS Lett 410: 49-53, 1997.
18. 2 and fatty acids in human colon tumours and associated normal tissue. Eur J Cancer 32A: 1781-1787, 1996.
19. 2 in human colorectal cancer. Anticancer Res 18: 3283-3287, 1998.
20. 2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res 11: 2265-2271, 2005. (Pubitemid 40490186)
21. 2. Carcinogenesis 25: 1517-1524, 2004.
22. 2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 24: 307-315, 2003.
23. 2 deletion enhances colon tumorigenesis. Cancer Res 65: 2636-2643, 2005. (Pubitemid 40490062)
24. Ko HM, Seo KH, Han SJ, Ahn KY, Choi IH, Koh GY, Lee HK, Ra MS and Im SY: NF-κB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 62: 1809-1814, 2002.
25. Ko HM, Kang JH, Jung B, Kim HA, Park SJ, Kim KJ, Kang YR, Lee HK and Im SY: Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis. Int J Cancer 120: 1277-1283, 2007. (Pubitemid 46256781)
26. Im SY, Han SJ, Ko HM, Choi JH, Chun SB, Lee DG, Ha TY and Lee HK: Involvement of nuclear factor (NF)-κB in platelet-activating factor-mediated tumor necrosis factor-α expression. Eur J Immunol 27: 2800-2804, 1997.
27. Choi IH, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, Kwon KS, Lee MS, Ha TY and Lee HK: Platelet-activating factor-mediated NF-κB-dependency of a late anaphylactic reaction. J Exp Med. 198: 145-151, 2003.
28. Seo KH, Ko HM, Kim HA, Choi JH, Park SJ, Kim KJ, Lee HK and Im SY: Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through NF-κB activation. Cancer Res 66: 4681-4687, 2006.
29. 2 activation. Int Arch Allergy Immunol 147: 315-322, 2008.
30. Takaku K, Sonoshita M, Sasaki N, Uozumi N, Doi Y, Shimizu T and Taketo MM: Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J Biol Chem 275: 34013-34016, 2000.
31. 2 suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci USA 98: 3935-3939, 2001.
32. 2. Carcinogenesis 25: 1517-1524, 2004.
33. 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. Cancer Res 69: 1733-1738, 2009.
34. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclo-oxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994. (Pubitemid 24294584)
35. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S and Talbot IC: Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187: 295-301, 1999.
36. 2 in human colon cancer cells. Cancer Res 58: 362-366, 1998.
37. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081, 2001. (Pubitemid 37411372)
38. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A and Mulshine JL: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813, 1996.
39. Ghosh J and Myers CE: Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235: 418-423, 1997.
40. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA and Xu XC: Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26: 785-791, 2005.
41. Anderson KM, Alrefai WA, Bonomi PA, Anderson CA, Dudeja P and Harris JE: A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA array. Anticancer Res 20: 2433-2439, 2000. (Pubitemid 30614448)
42. Ghosh J and Myers CE: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95: 13182-13187, 1998.
43. Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM and Adrian TE: Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8: 3232-3242, 2002.
44. Ding XZ, Talamonti MS, Bell RH Jr and Adrian TE: A novel anti-pancreatic cancer agent, LY293111. Anticancer Drugs 16: 467-473, 2005.
45. Fidler I and Ellis L: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-184, 1994.
46. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori, M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998. (Pubitemid 28257578)
47. Williams CS, Tsujii M, Reese J, Dey SK and DuBois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105: 1589-1594, 2000. (Pubitemid 30390309)
48. Romano M, Catalano A, Nutini M, D'Urbano E, Crescenzi C, Clària J, Libner R, Davi G and Procopio A: 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB J 15: 2326-2336, 2001.
49. Nagase H and Woessner JF Jr.: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
50. Titos E, Clària J, Planagumà A, López-Parra M, González-Périz A, Gaya J, Miquel R, Arroyo V and Rodés J: Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. J Leukoc Biol 78: 871-878, 2005.
51. Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lötzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ and Funk CD: The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10: 966-973, 2004.
52. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ and Patierno SR: Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60: 4629-4637, 2000.
53. 2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 27: 50828-50833, 2002.